Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: Implications for future national cancer control planning
Authors/Creators
- 1. Institute of Cancer Policy, Cancer Epidemiology, Population & Global Health, School of Cancer Sciences, King's College London, UK
- 2. Medical University of Gdansk, Dept. of Oncology and Radiotherapy, Gdansk, Poland
- 3. Romanian Health Observatory, Bucharest, Romania
- 4. University Clinic Golnik, Medical Faculty Ljubljana, Slovenia
- 5. Asfendiyarov Kazakh National Medical University, Republic of Kazakhstan
- 6. Federal Oncology Commission of the Ministry of Health of Russia, Moscow, Russian Federation
- 7. FAAP, Hacettepe University Faculty of Medicine and Cancer Institute,
- 8. Department of Health Policy & Health Economics, Eötvös Loránd University, Syreon Research Institute, Budapest, Hungary
- 9. Department of Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
- 10. Department of Oncology, Clinical Hospital Center Split, School of Medicine, University of Split, Split, Croatia
- 11. Cancer Institute "Ion Chiricuta", Department of Breast Tumors, Head of the Day Hospital Unit, Republicii 34-36, 400015, Cluj-Napoca, Romania
- 12. Maria Sklodowska-Curie Institute Oncology Center, Warszawa, Poland
- 13. Institute of Cancer Policy, Cancer Epidemiology, Population & Global Health, School of Cancer Sciences, King's College London & Guy's & St.Thomas' NHS Trust, London, UK
- 14. Centre for Cancer Research and Cell Biology, Queen's University Belfast, 97 Lisburn Rd, Belfast, BT9 7AE, UK
Description
Abstract Cancer research is an essential part of national cancer control programmes, and the
emerging economies of Central and Eastern Europe (CEE) and the Russian Federation and
Central Asia (R-CA) (Commonwealth of Independent States) remain relatively understudied.
Here, we map the cancer research activity from the 29 countries across these regions over a 10-
year period (2007e2016), using a standard scientometric approach. Research activity was
compared with the countries’ wealth and with the disease burden from different cancers,
and analyses were also performed by the research domain (e.g. fundamental cancer biology,
surgery). We found that although there was a correlation between outputs and national
wealth, there were many outliers; the CEE countries publishing relatively more, and the RCA,
less. Outputs reflected cancer burdens, but there was a relative paucity of research on
lung, colorectal, gastric and pancreatic cancer, as well as research domains such as screening
and palliative care. Clinical trials accounted for only 3% of all research outputs from all countries,
and were very international, with on average 1.5 CEE countries and 8.0 others involved
in each article, and they were heavily cited (on average, 84 times in 5 years). Poland was by far
the most research-active country, but significant needs and opportunities have been identified
to expand the cancer research activity in all CEE and R-CA countries to enhance national cancer
control planning.
Notes
Files
Restricted
The record is publicly accessible, but files are restricted. <a href="https://zenodo.org/account/settings/login?next=https://zenodo.org/records/3993088">Log in</a> to check if you have access.
Additional details
Related works
- Is documented by
- 30347288 (PMID)
- Is source of
- 0959-8049 (ISSN)